Today during trading, Biosyent Inc shares opened at $8.50 and closed at $8.51. It traded at a low of $8.50 to a high of $8.51.

The price advanced 1.31 percent from the previous day's close of $8.40.

Today across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 7,093 shares was traded during the last trading day, with total trades of 15, with an average volume of 16,310 over the last 5 days.

Trading across the entire TSX-V saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 52 weeks, Biosyent Inc's shares have advanced 6.38 percent, while in 2024, they have eased -7.70%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $97.52 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc's average recommendation is "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..